The Zacks Analyst Blog Highlights Johnson & Johnson, The Home Depot, Micron Technology, Autoscope Technologies and Nova LifeStyle

For Immediate ReleaseChicago, IL – July 3, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Johnson & Johnson JNJ, The Home Depot, Inc. HD and Micron Technology, Inc. MU, Autoscope Technologies Corp. AATC and Nova LifeStyle, Inc. NVFY.Here are highlights from Wednesday’s Analyst Blog:Top Analyst Reports for Johnson & Johnson, Home Depot and MicronThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson, The Home Depot, Inc. and Micron Technology, Inc., as well as two micro-cap stocks Autoscope Technologies Corp. and Nova LifeStyle, Inc.. The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.You can see all of today's research reports here >>>Ahead of Wall StreetThe daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens and attempts to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.You can read today's AWS here >>> ADP Private-Sector Payrolls -33K, Worst in 2+ YearsToday's Featured Research ReportsJohnson & Johnson's shares have outperformed the Zacks Large Cap Pharmaceuticals industry over the year-to-date period (+9.4% vs. +0.8%). The company's Innovative Medicine unit is showing a growth trend, driven by existing products like Darzalex, Tremfya and Erleada and continued uptake of new launches, including Spravato, Carvykti and Tecvayli. J&J is making rapid progress with its pipeline and has been on an acquisition spree lately, which has strengthened its pipeline.However, sales in the MedTech segment have slowed down due to headwinds in Asia-Pacific markets like China and competitive pressure in some categories. The launch of Stelara generics has been eroding the drug's sales in 2025. Uncertainties around talc lawsuits remain. The potential impact of pharma tariffs in the uncertain economic landscape remains an overhang.(You can read the full research report on Johnson & Johnson here >>>)Shares of Home Depot have outperformed the Zacks Retail - Home Furnishings industry over the past year (+14.0% vs. +10.5%). The company continues to benefit from its progress in building an interconnected shopping experience, synergies from the SRS acquisition, expansion of its Pro ecosystem, strategic digital investments, and new store openings.These factors contributed to robust top-line growth in the first quarter of fiscal 2025, driven by increased engagement in spring-related purchases and smaller-scale home improvement projects.However, HD faces softer demand in big-ticket discretionary categories, reflecting consumer caution amid high interest rates. Margin pressure, currency headwinds, and macroeconomic uncertainty also remain key risks. HD is also navigating a complex global trade environment, with rising tariffs.(You can read the full research report on Home Depot here >>>)Micron Technology's shares have outperformed the Zacks Computer - Integrated Systems industry over the year-to-date period (+42.5% vs. +26.5%). The company's latest quarterly performance underscores its strategic positioning in the rapidly expanding AI-driven memory and storage markets. The positive impact of inventory improvement across multiple end markets is adding to the top-line growth.The surging demand for HBM and robust DRAM pricing recovery will aid significant revenue and earnings growth in the coming quarters. Its solid financials, positive free cash flow and strong balance sheet provide the flexibility to invest in growth initiatives while enhancing shareholder value. Its long-term customer agreements and expanding AI partnerships reduce volatility and enhance revenue visibility.However, weakness in NAND pricing due to oversupply conditions and slower-than-expected demand recovery might hurt overall financial performance. An escalating trade war is another concern.(You can read the full research report on Micron Technology here >>>)Shares of Autoscope Technologies have outperformed the Zacks Technology Services industry over the past year (+41.5% vs. +38.3%). This microcap company with market capitalization of $40.70 million offers a resilient, royalty-driven business model with a 100% gross margin due to fully amortized software costs and outsourced production. Despite a 32% drop in first-quarter 2025 royalty revenues, margins and cash flows remained robust, supported by recurring royalties (97% of revenues).Cost discipline preserved a 20.3% operating margin and 7 cents EPS amid a 30% revenue decline. The launch of Autoscope Analytics and a strong surge in product revenues (more than 319% year over year) expand TAM and diversify income streams. Capital-light operations enable flexibility and dividends without compromising liquidity or innovation.Additionally, Autoscope is well-positioned to benefit from U.S. government-funded Smart City and traffic safety programs, leveraging its broad installed base and exclusive distribution with Econolite.(You can read the full research report on Autoscope Technologies here >>>)Nova LifeStyle's shares have outperformed the Zacks Furniture industry over the year-to-date period (+109.6% vs. -16.8%). This microcap company with market capitalization of $19.33 million pivot to premium furniture continues to drive margin expansion, with gross margin rising to 46% in first-quarter 2025, supported by a 26% ASP increase offsetting a 12% volume decline, signaling strong premium brand positioning.Operating loss narrowed significantly due to deep cost cuts, though net losses persist. Revenues rose 10.9% year over year, driven solely by pricing, highlighting volume and diversification concerns. Liquidity remains constrained amid surging supplier prepayments and minimal cash.Revenue growth remains ASP-led amid shrinking volume and geographic reach. Supply chain fragility and uncertain tariff policy add cost volatility. While valuation appears modest, execution risks, scalability doubts, delisting risks and financial fragility temper optimism around NVFY's high-margin transformation strategy.(You can read the full research report on Nova LifeStyle here >>>)Why Haven't You Looked at Zacks' Top Stocks?Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.Today you can access their live picks without cost or obligation.See Stocks Free >>Media ContactZacks Investment Research800-767-3771 ext. 9339support@zacks.com                                      https://www.zacks.com                                                   Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Johnson & Johnson (JNJ): Free Stock Analysis Report Micron Technology, Inc. (MU): Free Stock Analysis Report The Home Depot, Inc. (HD): Free Stock Analysis Report Nova Lifestyle, Inc (NVFY): Get Free Report Autoscope Technologies Corporation (AATC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks